Planet Biotechnology
As President and CEO of Neurobiological Technologies Inc., Richmond, CA (until May, 1997), Dr. Price raised approximately $30 million, including an IPO in February 1994, and brought four products into phase II clinical trials.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Planet Biotechnology
1 followers
Planet Biotechnology is a clinical-stage company that develops monoclonal antibody-based therapeutic and preventative products.